APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phenprocoumon

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Phenprocoumon Industry Growth and Trends Forecast to 2032

20 December 202591 pages

Choose your research edition.

Industry ResearchPhenprocoumon Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Phenprocoumon Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Phenprocoumon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phenprocoumon Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Phenprocoumon Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Phenprocoumon market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Phenprocoumon is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Phenprocoumon is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phenprocoumon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Phenprocoumon include Teva, Novartis, Mylan, Roche, Wörwag Pharma, Divis Labs, Aspen Pharmacare and Acis Arzneimittel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Phenprocoumon market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Phenprocoumon market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Phenprocoumon market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Phenprocoumon.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Phenprocoumon market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Phenprocoumon Market by Company

Teva

Novartis

Mylan

Roche

Wörwag Pharma

Divis Labs

Aspen Pharmacare

Acis Arzneimittel

Phenprocoumon Segment by Type

5 mg

10 mg

25 mg

50 mg

Phenprocoumon Segment by Application

Pulmonary Embolism

Venous Thrombosis

Thromboembolism

Others

Phenprocoumon Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phenprocoumon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phenprocoumon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phenprocoumon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Phenprocoumon manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Phenprocoumon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5 mg Table 2. Major Company of 10 mg Table 3. Major Company of 25 mg Table 4. Major Company of 50 mg Table 5. Global Phenprocoumon Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 7. Global Phenprocoumon Sales Market Share in Volume by Type (2021-2026) Table 8. Global Phenprocoumon Sales by Type (2021-2026) & (US$ Million) Table 9. Global Phenprocoumon Sales Market Share in Value by Type (2021-2026) Table 10. Global Phenprocoumon Price by Type (2021-2026) & (US$/Unit) Table 11. Global Phenprocoumon Sales by Type (2027-2032) & (K Units) Table 12. Global Phenprocoumon Sales Market Share in Volume by Type (2027-2032) Table 13. Global Phenprocoumon Sales by Type (2027-2032) & (US$ Million) Table 14. Global Phenprocoumon Sales Market Share in Value by Type (2027-2032) Table 15. Global Phenprocoumon Price by Type (2027-2032) & (US$/Unit) Table 16. North America Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 17. North America Phenprocoumon Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 19. Europe Phenprocoumon Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Phenprocoumon Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 23. Latin America Phenprocoumon Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Phenprocoumon Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Phenprocoumon Sales by Type (2021-2026) & (US$ Million) Table 26. Phenprocoumon Industry Trends Table 27. Phenprocoumon Industry Drivers Table 28. Phenprocoumon Industry Opportunities and Challenges Table 29. Phenprocoumon Industry Restraints Table 30. Global Phenprocoumon Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Phenprocoumon Revenue Market Share by Company (2021-2026) Table 32. Global Phenprocoumon Sales by Company (2021-2026) & (K Units) Table 33. Global Phenprocoumon Sales Share by Company (2021-2026) Table 34. Global Phenprocoumon Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Phenprocoumon Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Phenprocoumon Major Company Production Sites and Headquarters Table 37. Global Phenprocoumon Company, Product Type & Application Table 38. Global Phenprocoumon Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Phenprocoumon by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Phenprocoumon Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Phenprocoumon Sales by Region (2021-2026) & (K Units) Table 43. Global Phenprocoumon Sales Market Share in Volume by Region (2021-2026) Table 44. Global Phenprocoumon Sales by Region (2021-2026) & (US$ Million) Table 45. Global Phenprocoumon Sales Market Share in Value by Region (2021-2026) Table 46. Global Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Phenprocoumon Sales by Region (2027-2032) & (K Units) Table 48. Global Phenprocoumon Sales Market Share in Volume by Region (2027-2032) Table 49. Global Phenprocoumon Sales by Region (2027-2032) & (US$ Million) Table 50. Global Phenprocoumon Sales Market Share in Value by Region (2027-2032) Table 51. Global Phenprocoumon Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Phenprocoumon Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 54. Global Phenprocoumon Sales Market Share in Volume by Application (2021-2026) Table 55. Global Phenprocoumon Sales by Application (2021-2026) & (US$ Million) Table 56. Global Phenprocoumon Sales Market Share in Value by Application (2021-2026) Table 57. Global Phenprocoumon Price by Application (2021-2026) & (US$/Unit) Table 58. Global Phenprocoumon Sales by Application (2027-2032) & (K Units) Table 59. Global Phenprocoumon Sales Market Share in Volume by Application (2027-2032) Table 60. Global Phenprocoumon Sales by Application (2027-2032) & (US$ Million) Table 61. Global Phenprocoumon Sales Market Share in Value by Application (2027-2032) Table 62. Global Phenprocoumon Price by Application (2027-2032) & (US$/Unit) Table 63. North America Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 64. North America Phenprocoumon Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 66. Europe Phenprocoumon Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Phenprocoumon Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 70. Latin America Phenprocoumon Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Phenprocoumon Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Phenprocoumon Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Phenprocoumon Product Portfolio Table 77. Teva Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Novartis Phenprocoumon Product Portfolio Table 82. Novartis Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mylan Phenprocoumon Product Portfolio Table 87. Mylan Recent Development Table 88. Roche Company Information Table 89. Roche Business Overview Table 90. Roche Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Roche Phenprocoumon Product Portfolio Table 92. Roche Recent Development Table 93. Wörwag Pharma Company Information Table 94. Wörwag Pharma Business Overview Table 95. Wörwag Pharma Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Wörwag Pharma Phenprocoumon Product Portfolio Table 97. Wörwag Pharma Recent Development Table 98. Divis Labs Company Information Table 99. Divis Labs Business Overview Table 100. Divis Labs Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Divis Labs Phenprocoumon Product Portfolio Table 102. Divis Labs Recent Development Table 103. Aspen Pharmacare Company Information Table 104. Aspen Pharmacare Business Overview Table 105. Aspen Pharmacare Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Aspen Pharmacare Phenprocoumon Product Portfolio Table 107. Aspen Pharmacare Recent Development Table 108. Acis Arzneimittel Company Information Table 109. Acis Arzneimittel Business Overview Table 110. Acis Arzneimittel Phenprocoumon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Acis Arzneimittel Phenprocoumon Product Portfolio Table 112. Acis Arzneimittel Recent Development Table 113. North America Phenprocoumon Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. North America Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 115. North America Phenprocoumon Sales Market Share by Country (2021-2026) Table 116. North America Phenprocoumon Sales Forecast by Country (2027-2032) & (K Units) Table 117. North America Phenprocoumon Sales Market Share Forecast by Country (2027-2032) Table 118. North America Phenprocoumon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Phenprocoumon Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Phenprocoumon Market Share by Country (2021-2026) Table 121. North America Phenprocoumon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Phenprocoumon Market Share Forecast by Country (2027-2032) Table 123. Europe Phenprocoumon Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Europe Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 125. Europe Phenprocoumon Sales Market Share by Country (2021-2026) Table 126. Europe Phenprocoumon Sales Forecast by Country (2027-2032) & (K Units) Table 127. Europe Phenprocoumon Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Phenprocoumon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Phenprocoumon Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Phenprocoumon Market Share by Country (2021-2026) Table 131. Europe Phenprocoumon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Phenprocoumon Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Phenprocoumon Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 135. Asia-Pacific Phenprocoumon Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Phenprocoumon Sales Forecast by Country (2027-2032) & (K Units) Table 137. Asia-Pacific Phenprocoumon Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Phenprocoumon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Phenprocoumon Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Phenprocoumon Market Share by Country (2021-2026) Table 141. Asia-Pacific Phenprocoumon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Phenprocoumon Market Share Forecast by Country (2027-2032) Table 143. Latin America Phenprocoumon Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Latin America Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 145. Latin America Phenprocoumon Sales Market Share by Country (2021-2026) Table 146. Latin America Phenprocoumon Sales Forecast by Country (2027-2032) & (K Units) Table 147. Latin America Phenprocoumon Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Phenprocoumon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Phenprocoumon Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Phenprocoumon Market Share by Country (2021-2026) Table 151. Latin America Phenprocoumon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Phenprocoumon Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Phenprocoumon Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Phenprocoumon Sales by Country (2021-2026) & (K Units) Table 155. Middle East and Africa Phenprocoumon Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Phenprocoumon Sales Forecast by Country (2027-2032) & (K Units) Table 157. Middle East and Africa Phenprocoumon Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Phenprocoumon Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Phenprocoumon Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Phenprocoumon Market Share by Country (2021-2026) Table 161. Middle East and Africa Phenprocoumon Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Phenprocoumon Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Phenprocoumon Distributors List Table 166. Phenprocoumon Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Phenprocoumon Image Figure 2. Global Phenprocoumon Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phenprocoumon Market Size (2021-2032) & (US$ Million) Figure 4. Global Phenprocoumon Sales (2021-2032) & (K Units) Figure 5. 5 mg Image Figure 6. Global 5 mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10 mg Image Figure 8. Global 10 mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 25 mg Image Figure 10. Global 25 mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. 50 mg Image Figure 12. Global 50 mg Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Phenprocoumon Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Phenprocoumon Market Share by Type 2025 VS 2032 Figure 15. North America Phenprocoumon Sales Market Share in Volume by Type in 2025 Figure 16. North America Phenprocoumon Sales Market Share in Value by Type in 2025 Figure 17. Europe Phenprocoumon Sales Market Share in Volume by Type in 2025 Figure 18. Europe Phenprocoumon Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Phenprocoumon Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Phenprocoumon Sales Market Share in Value by Type in 2025 Figure 21. Latin America Phenprocoumon Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Phenprocoumon Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Phenprocoumon Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Phenprocoumon Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Phenprocoumon Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pulmonary Embolism Image Figure 28. Global Pulmonary Embolism Sales YoY Growth (2021-2032) & (K Units) Figure 29. Venous Thrombosis Image Figure 30. Global Venous Thrombosis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Thromboembolism Image Figure 32. Global Thromboembolism Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Phenprocoumon Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Phenprocoumon Market Share by Application 2025 VS 2032 Figure 37. North America Phenprocoumon Sales Market Share in Volume by Application in 2025 Figure 38. North America Phenprocoumon Sales Market Share in Value by Application in 2025 Figure 39. Europe Phenprocoumon Sales Market Share in Volume by Application in 2025 Figure 40. Europe Phenprocoumon Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Phenprocoumon Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Phenprocoumon Sales Market Share in Value by Application in 2025 Figure 43. Latin America Phenprocoumon Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Phenprocoumon Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Phenprocoumon Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Phenprocoumon Sales Market Share in Value by Application in 2025 Figure 47. North America Phenprocoumon Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Phenprocoumon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Phenprocoumon Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Phenprocoumon Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Phenprocoumon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Phenprocoumon Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Phenprocoumon Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Phenprocoumon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Phenprocoumon Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Phenprocoumon Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Phenprocoumon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Phenprocoumon Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Phenprocoumon Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Phenprocoumon Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Phenprocoumon Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Phenprocoumon Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Phenprocoumon Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Phenprocoumon Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg
  • 10 mg
  • 25 mg
  • 50 mg
Applications
  • Pulmonary Embolism
  • Venous Thrombosis
  • Thromboembolism
  • Others
Companies covered
  • Teva
  • Novartis
  • Mylan
  • Roche
  • Wörwag Pharma
  • Divis Labs
  • Aspen Pharmacare
  • Acis Arzneimittel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Phenprocoumon Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Phenprocoumon Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Phenprocoumon Market by Type
  6. 1.3.1 5 mg
  7. 1.3.2 10 mg
  8. 1.3.3 25 mg
  9. 1.3.4 50 mg
  10. 1.4 Global Phenprocoumon Market Size by Type
  11. 1.4.1 Global Phenprocoumon Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Phenprocoumon Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Phenprocoumon Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Phenprocoumon Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Phenprocoumon Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Phenprocoumon Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Phenprocoumon Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Phenprocoumon Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Phenprocoumon Industry Trends
  2. 2.2 Phenprocoumon Industry Drivers
  3. 2.3 Phenprocoumon Industry Opportunities and Challenges
  4. 2.4 Phenprocoumon Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Phenprocoumon Revenue (2021-2026)
  2. 3.2 Global Top Players by Phenprocoumon Sales (2021-2026)
  3. 3.3 Global Top Players by Phenprocoumon Price (2021-2026)
  4. 3.4 Global Phenprocoumon Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Phenprocoumon Major Company Production Sites & Headquarters
  6. 3.6 Global Phenprocoumon Company, Product Type & Application
  7. 3.7 Global Phenprocoumon Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Phenprocoumon Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Phenprocoumon Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Phenprocoumon Tier 1, Tier 2, and Tier 3
4 Phenprocoumon Regional Status and Outlook
  1. 4.1 Global Phenprocoumon Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Phenprocoumon Historic Market Size by Region
  3. 4.2.1 Global Phenprocoumon Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Phenprocoumon Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Phenprocoumon Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Phenprocoumon Forecasted Market Size by Region
  7. 4.3.1 Global Phenprocoumon Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Phenprocoumon Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Phenprocoumon Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Phenprocoumon by Application
  1. 5.1 Phenprocoumon Market by Application
  2. 5.1.1 Pulmonary Embolism
  3. 5.1.2 Venous Thrombosis
  4. 5.1.3 Thromboembolism
  5. 5.1.4 Others
  6. 5.2 Global Phenprocoumon Market Size by Application
  7. 5.2.1 Global Phenprocoumon Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Phenprocoumon Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Phenprocoumon Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Phenprocoumon Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Phenprocoumon Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Phenprocoumon Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Phenprocoumon Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Phenprocoumon Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Phenprocoumon Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Phenprocoumon Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Phenprocoumon Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Phenprocoumon Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Wörwag Pharma
  26. 6.5.1 Wörwag Pharma Company Information
  27. 6.5.2 Wörwag Pharma Business Overview
  28. 6.5.3 Wörwag Pharma Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Wörwag Pharma Phenprocoumon Product Portfolio
  30. 6.5.5 Wörwag Pharma Recent Developments
  31. 6.6 Divis Labs
  32. 6.6.1 Divis Labs Company Information
  33. 6.6.2 Divis Labs Business Overview
  34. 6.6.3 Divis Labs Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Divis Labs Phenprocoumon Product Portfolio
  36. 6.6.5 Divis Labs Recent Developments
  37. 6.7 Aspen Pharmacare
  38. 6.7.1 Aspen Pharmacare Company Information
  39. 6.7.2 Aspen Pharmacare Business Overview
  40. 6.7.3 Aspen Pharmacare Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aspen Pharmacare Phenprocoumon Product Portfolio
  42. 6.7.5 Aspen Pharmacare Recent Developments
  43. 6.8 Acis Arzneimittel
  44. 6.8.1 Acis Arzneimittel Company Information
  45. 6.8.2 Acis Arzneimittel Business Overview
  46. 6.8.3 Acis Arzneimittel Phenprocoumon Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Acis Arzneimittel Phenprocoumon Product Portfolio
  48. 6.8.5 Acis Arzneimittel Recent Developments
7 North America by Country
  1. 7.1 North America Phenprocoumon Sales by Country
  2. 7.1.1 North America Phenprocoumon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Phenprocoumon Sales by Country (2021-2026)
  4. 7.1.3 North America Phenprocoumon Sales Forecast by Country (2027-2032)
  5. 7.2 North America Phenprocoumon Market Size by Country
  6. 7.2.1 North America Phenprocoumon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Phenprocoumon Market Size by Country (2021-2026)
  8. 7.2.3 North America Phenprocoumon Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Phenprocoumon Sales by Country
  2. 8.1.1 Europe Phenprocoumon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Phenprocoumon Sales by Country (2021-2026)
  4. 8.1.3 Europe Phenprocoumon Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Phenprocoumon Market Size by Country
  6. 8.2.1 Europe Phenprocoumon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Phenprocoumon Market Size by Country (2021-2026)
  8. 8.2.3 Europe Phenprocoumon Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Phenprocoumon Sales by Country
  2. 9.1.1 Asia-Pacific Phenprocoumon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Phenprocoumon Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Phenprocoumon Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Phenprocoumon Market Size by Country
  6. 9.2.1 Asia-Pacific Phenprocoumon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Phenprocoumon Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Phenprocoumon Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Phenprocoumon Sales by Country
  2. 10.1.1 South America Phenprocoumon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Phenprocoumon Sales by Country (2021-2026)
  4. 10.1.3 South America Phenprocoumon Sales Forecast by Country (2027-2032)
  5. 10.2 South America Phenprocoumon Market Size by Country
  6. 10.2.1 South America Phenprocoumon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Phenprocoumon Market Size by Country (2021-2026)
  8. 10.2.3 South America Phenprocoumon Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Phenprocoumon Sales by Country
  2. 11.1.1 Middle East and Africa Phenprocoumon Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Phenprocoumon Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Phenprocoumon Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Phenprocoumon Market Size by Country
  6. 11.2.1 Middle East and Africa Phenprocoumon Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Phenprocoumon Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Phenprocoumon Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Phenprocoumon Value Chain Analysis
  2. 12.1.1 Phenprocoumon Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Phenprocoumon Production Mode & Process
  7. 12.2 Phenprocoumon Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Phenprocoumon Distributors
  10. 12.2.3 Phenprocoumon Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst